Understanding how epigenetics affects tissue regeneration

Delineating epigenetic coordination of regenerative cell plasticity

NIH-funded research Columbia University Health Sciences · NIH-10913522

This study is looking at how certain genes help our body heal and repair skin and other tissues after injuries, especially by working with immune cells, which could lead to new treatments for wounds, lung problems, and cancer.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionColumbia University Health Sciences NIH-funded
Lab location1 site (New York, United States)
Project IDNIH-10913522 on NIH RePORTER

What this research studies

This research investigates the role of epigenetic modifiers in the regeneration of epithelial tissues, which are crucial for healing and repair after injury. By examining how these modifiers interact with immune cells, the research aims to uncover the mechanisms that enable tissue restoration. The approach includes a novel in vivo gene editing platform to manipulate and study these interactions in real-time. This could lead to new therapeutic strategies for conditions like wound healing, lung diseases, and cancer.

Who could benefit from this research

Good fit: Ideal candidates for this research include individuals with conditions affecting epithelial tissues, such as wounds, lung diseases, or cancers.

Not a fit: Patients with non-epithelial tissue conditions or those not experiencing tissue regeneration issues may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to innovative treatments that enhance tissue healing and regeneration for various diseases.

How similar studies have performed: Previous research has shown promise in understanding epigenetic mechanisms in tissue regeneration, suggesting that this approach could yield significant insights.

Where this research is happening

New York, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Cancers
Last reviewed 2026-06-09 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.